OMNI

About:

OMNI is a pharmaceutical company.

Top Investors: Vivo Capital, BioVenture, SDIC Venture Capital, Shanghai Biomedical Industrial Equity Investment Fund, Bank of China Group Investment

Description:

OMNI is an innovative pharmaceutical company focusing on the development of drug delivery technology. OMNI provides inhalation dosage forms, including inhalation aerosol, inhalation powder aerosol, inhalation nebulized solution, and nasal spray, and a design platform for supporting respiratory devices for asthma and chronic obstructive pulmonary disease.

Total Funding Amount:

33M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2011-01-01

Contact Email:

bd(AT)omni-pharma.com

Founders:

Cai Xin, Zeng Zhaotrit, Zhang Kai

Number of Employees:

251-500

Last Funding Date:

2021-12-27

IPO Status:

Private

Industries: